Get the latest Venture Capital & Angel investors news and info Join Our Mailing List:

Your Name: 

Your Email:  

*By submitting your name & email you agree to receive for FREE our scholarships & offers Newsletters. You agree also with the storage and handling of your data by this website and 3rd party email services.
You may unsubscribe if you wish. And you can delete your email and name at any time by emailing us to the email on the bottom of this page.

Follow us on
 
  • 3i joins as new investor in Sweden's Carmel Pharma

    December 20th, 2005 No comments

    SLS Venture has signed an agreement to sell about 23 % of Carmel Pharma to 3i, Europe’s leading venture capital and private equity company. 3i will also participate in the company’s present issue of new shares.

    Carmel Pharma is a company in Sweden that manufactures and markets PhaSeal, a product system for the handling of toxic drugs, and minimizing the spread of aerosols into the work environment. Carmel Pharma is one of the fastest growing technology companies in Europe, the Middle East and Africa.

    Most Swedish national hospitals treating cancer patients use PhaSeal products. Carmel Pharma primary market today is the USA, and has expanded its operations to the US in recent years. Hundreds of American hospitals use the product on a routine basis and the company’s sales volumes have grown nearly 40% in the past year alone, and are expected to grow more in 2006.

    Thomas Pollare, Partner, Venture Team, 3i Nordic says: “Carmel Pharma is an exciting company in expansion phase. PhaSeal has great development opportunities and we strongly believe in Managing Director Dan Pitulia and his management team’s ability to successfully take the company to the next stage. Based on 3i’s long medtech investing experience and international network contacts and resource, we look forward to actively helping Carmel Pharma with its international expansion.”

    Dan Pitulia, Managing Director, Carmel Pharma, comments: “It is great to have 3i backing our company. In 3i we will have a new financially strong partner with an international network and long experience on business development. Our objective is to further strengthen our world leading position through strong organic growth.”

Leave a reply

Please leave these two fields as-is:

Protected by Invisible Defender. Showed 403 to 252,661 bad guys.

 

Latest Headlines:

Friday August 31, 2012
Zscaler Secures $38 Million Investment Round


Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.


Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects


Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding


Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies


Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains


Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster


Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility


 

By using this website you agree with our cookie policy